Merrimack PharmaceuticalsMACK
13F holders, Q3 2024 (September 30)2holders −10
0new positions
10sold out
$0.00avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Merrimack Pharmaceuticals Inc. (MACK) in their 13F filings, down 10 from Q2 2024. 0 opened new positions and 10 sold out. The largest holders were Rise Advisors, LLC ($0) and Farther Finance Advisors, LLC ($0).
- Company
- Merrimack Pharmaceuticals Inc.
- CUSIP
- 590328209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 10 | $5.3M |
All 13F filers, Q2 2024 → Q3 2024: 436,972 shares sold, net −436,972 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Rise Advisors, LLC | 0.00% | No change | 272 | $0 |
| Farther Finance Advisors, LLC | 0.00% | No change | 77 | $0 |
"% of holder's portfolio" is MACK's weight in each manager's 13F, not the share of Merrimack Pharmaceuticals Inc. the manager owns.